Intrathecal Application of PD1 Antibody in Metastatic Solid Tumors With Leptomeningeal Disease (IT-PD1/ NOA 26)
NCT05112549
·
clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
46
Enrollment
OTHER
Sponsor class
Conditions
Leptomeningeal Disease
Interventions
DRUG:
Nivolumab [Opdivo]
Sponsor
University Hospital Tuebingen